← SynDRA
BMY-14802
SynDRA canonical compound SYN0002747 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | HTR1A |
| Mechanism of action | Sigma receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Sigma receptor antagonist
- HTR1A FULL AGONIST
- SIGMAR1 MODULATOR
- HTR1A MODULATOR
Cross-references
Synonyms
- BMS-181100
- BMY-14786
- BMY-14802 hydrochloride
- MJ-14676
- MJ-14786
- MJ-14802
- BMY-14802, Skybridge
- BMY-14802-1
- BMY-14802 (dyskinesia), Skybridge
- 5-HT 1a receptor agonist (dyskinesia), Skybridge
- A5NB5G07JO
- RefChem:120802
- (A+-)-BMY-14802
- BMY-14802-1 Free
- ZXUYYZPJUGQHLQ-UHFFFAOYSA-N
- GTPL8
- (+-)-BMS 14802
- UNII-A5NB5G07JO
- SCHEMBL467229
- orb1685601
- CHEBI:91549
- BMY14802
- BDBM50002238
- PDSP1_000017
- PDSP2_000017
- DA-50350
- MS-25366
- HY-153091
- (+/-)-BMY-14802
- CS-0650370
- BMY-14802, >=97% (HPLC)
- H37191
- T67739
- L023990
- BRD-A15435692-003-01-5
- BRD-A15435692-003-02-3
- BMY 14802
- BMY 14802 HCl
Look up BMY-14802 in the interactive SynDRA portal →